XML 37 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Detail) - Summary Of Changes In SARs Outstanding (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2014
Dec. 31, 2013
Weighted Average Remaining Contractual Term [Roll Forward]    
Granted 2 years 7 months 35 days  
Stock appreciation rights (SARs)
   
SARs [Roll Forward]    
Outstanding at December 31, 2013 (in shares) 1,600,000  
Granted (in shares) 400,000  
Forfeited (in shares) 0  
Exercised (in shares) 0  
Outstanding at March 31, 2014 (in shares) 2,000,000 [1],[2] 1,600,000
Vested and exercisable at March 31, 2014 (in shares) 1,000,000 [1]  
Per Share Weighted- Average Exercise Price [Roll Forward]    
Outstanding at December 31, 2013 (in Dollars per share) $ 34.14  
Granted (in Dollars per share) $ 64.64  
Forfeited (in Dollars per share) $ 0.00  
Exercised (in Dollars per share) $ 30.15  
Outstanding at March 31, 2014 (in Dollars per share) $ 40.28 [1],[2] $ 34.14
Vested and exercisable at March 31, 2014 (in Dollars per share) $ 29.27 [1]  
Per Share Weighted Average Grant Date Fair Value [Roll Forward]    
Outstanding at December 31, 2013 (in Dollars per share) $ 11.63  
Granted (in Dollars per share) $ 14.99  
Forfeited (in Dollars per share) $ 0.00  
Exercised (in Dollars per share) $ 10.56  
Outstanding at March 31, 2014 (in Dollars per share) $ 12.31 [1],[2] $ 11.63
Vested and exercisable at March 31, 2014 (in Dollars per share) $ 10.39 [1]  
Weighted Average Remaining Contractual Term [Roll Forward]    
Outstanding at December 31, 2013 4 years 7 months 24 days [1],[2] 4 years 4 months 2 days
Granted 6 years 10 months 15 days  
Vested and exercisable at March 31, 2014 3 years 6 months 5 days [1]  
[1] Total SARs outstanding had an intrinsic value of $57.0 million. SARs vested and exercisable had an intrinsic value of $40.9 million.
[2] As of March 31, 2014, 1.0 million of the SARs outstanding were unvested. The Company expects that substantially all of these unvested awards will vest in future periods.